In summary, this study has clarified the adverse pregnancy outcomes associated with intrahepatic cholestasis of pregnancy and has identified that women with serum bile acids of 100 µmol/L or more have a significantly increased risk of tillbirth. Future research should target mechanistic explanations for the increased risk of stillbirth in intrahepatic cholestasis of pregnancy and the potential of specific treatments to prevent fetal death.